Under construction – not a live service
Sign in
Taking people in NetherlandsPhase 1

Tests the safety of RO7568282 in healthy people and people with Parkinson's disease

Tests the drug RO7568282 for safety in adults with Parkinson's disease and healthy adults.

Key facts

Who runs it
F. Hoffmann-La Roche AG
Where
's-Hertogenbosch, Amsterdam, Groningen, Nijmegen, and Zwolle, NetherlandsSee the 5 sitesAlso in 2 other countries, 5 sites
Registry title
A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s disease.
Status
Recruiting
Phase
Phase 1
People taking part
150 people, planned
Started
9 Sept 2024
Expected to end
11 Apr 2028
Type of study
Interventional
Record updated
20 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy adults and adults with Parkinson's disease, to study how RO7568282 acts in the body and whether it is safe.

Age
18 years or older
Sex
All sexes can join

Where in Netherlands

Also in 2 other countries, 5 sites

  • Brain Research Center Den Bosch B.V.'s-Hertogenbosch, NetherlandsTaking people
  • Brain Research Center Amsterdam B.V.Amsterdam, NetherlandsTaking people
  • Pharmaceutical Research Associates Group B.V.Groningen, NetherlandsTaking people
  • Radboud universitair medisch centrum StichtingNijmegen, NetherlandsTaking people
  • Brain Research Center Zwolle B.V.Zwolle, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Tests the safety of RO7568282 in healthy people and people with Parkinson's diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
20 October 2026